_id
695fb8c2c2e91020a7bd42a2
Ticker
0IL8.LSE
Name
FibroGen, Inc.
Exchange
LSE
Address
350 Bay Street, San Francisco, CA, United States, 94133
Country
UK
Sector
Industry
Currency
USD
Website
https://www.fibrogen.com
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. Its pipeline products include FG-3165 and FG-3175, an anti-GAL-9 antibody for treatment of solid tumors. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
Last Close
9.23
Volume
1122
Current Price
9.4328
Last Updated
2026-01-08T14:01:38.426Z
Ipo Date
-
Market Cap
62909196800
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
1076000
Cost Of Revenue
-58000
Gross Profit
1134000
Operating Expenses
6545000
Operating Income
-5411000
Interest Expense
2083000
Pretax Income
-13146000
Net Income
200636000
Eps
49.61325420375866
Dividends Per Share
-
Shares Outstanding
84978096
Income Tax Expense
-
EBITDA
-10871000
Operating Margin
-502.88104089219325
Total Other Income Expense Net
-7735000
Cash
117975000
Short Term Investments
-
Receivables
121000
Inventories
3864000
Total Current Assets
133423000
Property Plant Equipment
-
Total Assets
137014000
Payables
5093000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
119529000
Equity
-17028000
Bs_currency_symbol
-
Depreciation
192000
Change In Working Capital
-160329000
Cash From Operations
-1847000
Capital Expenditures
9000
Cash From Investing
87160000
Cash From Financing
-85917000
Net Change In Cash
94608000
Cf_currency_symbol
-
PE
-
PB
-2.2402069062720225
ROE
-1178.2710829222458
ROA
146.4346709095421
FCF
-1856000
Fcf Percent
-1.724907063197026
Piotroski FScore
1
Health Score
32
Deep Value Investing Score
1.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
6.5
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1076000
Quarters > 0 > income Statement > cost Of Revenue
-58000
Quarters > 0 > income Statement > gross Profit
1134000
Quarters > 0 > income Statement > operating Expenses
6545000
Quarters > 0 > income Statement > operating Income
-5411000
Quarters > 0 > income Statement > interest Expense
2083000
Quarters > 0 > income Statement > pretax Income
-13146000
Quarters > 0 > income Statement > net Income
200636000
Quarters > 0 > income Statement > eps
49.61325420375866
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4044000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-10871000
Quarters > 0 > income Statement > operating Margin
-502.88104089219325
Quarters > 0 > income Statement > total Other Income Expense Net
-7735000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
117975000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
121000
Quarters > 0 > balance Sheet > inventories
3864000
Quarters > 0 > balance Sheet > total Current Assets
133423000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
137014000
Quarters > 0 > balance Sheet > payables
5093000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
119529000
Quarters > 0 > balance Sheet > equity
-17028000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-13146000
Quarters > 0 > cash Flow > depreciation
192000
Quarters > 0 > cash Flow > change In Working Capital
-160329000
Quarters > 0 > cash Flow > cash From Operations
-1847000
Quarters > 0 > cash Flow > capital Expenditures
9000
Quarters > 0 > cash Flow > cash From Investing
87160000
Quarters > 0 > cash Flow > cash From Financing
-85917000
Quarters > 0 > cash Flow > net Change In Cash
94608000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
49.61325420375866
Quarters > 0 > ratios > PB
-2.2402069062720225
Quarters > 0 > ratios > ROE
-1178.2710829222458
Quarters > 0 > ratios > ROA
146.4346709095421
Quarters > 0 > ratios > FCF
-1856000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.724907063197026
Quarters > 0 > health Score
32
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1348000
Quarters > 1 > income Statement > cost Of Revenue
85000
Quarters > 1 > income Statement > gross Profit
1263000
Quarters > 1 > income Statement > operating Expenses
13315000
Quarters > 1 > income Statement > operating Income
-12052000
Quarters > 1 > income Statement > interest Expense
2009000
Quarters > 1 > income Statement > pretax Income
-13775000
Quarters > 1 > income Statement > net Income
-7603000
Quarters > 1 > income Statement > eps
-1.8809995051954478
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
4042000
Quarters > 1 > income Statement > income Tax Expense
-92000
Quarters > 1 > income Statement > EBITDA
-11545000
Quarters > 1 > income Statement > operating Margin
-894.0652818991098
Quarters > 1 > income Statement > total Other Income Expense Net
-1723000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
23367000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
136000
Quarters > 1 > balance Sheet > inventories
3863000
Quarters > 1 > balance Sheet > total Current Assets
162322000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
178055000
Quarters > 1 > balance Sheet > payables
10477000
Quarters > 1 > balance Sheet > short Term Debt
73733000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
359085000
Quarters > 1 > balance Sheet > equity
-222997000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-7603000
Quarters > 1 > cash Flow > depreciation
221000
Quarters > 1 > cash Flow > change In Working Capital
17791000
Quarters > 1 > cash Flow > cash From Operations
12682000
Quarters > 1 > cash Flow > capital Expenditures
13000
Quarters > 1 > cash Flow > cash From Investing
-13000
Quarters > 1 > cash Flow > cash From Financing
-9000
Quarters > 1 > cash Flow > net Change In Cash
13641000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.8809995051954478
Quarters > 1 > ratios > PB
-0.1709770875841379
Quarters > 1 > ratios > ROE
3.4094629075727476
Quarters > 1 > ratios > ROA
-4.270028923647188
Quarters > 1 > ratios > FCF
12669000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
9.398367952522255
Quarters > 1 > health Score
37
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
2739000
Quarters > 2 > income Statement > cost Of Revenue
252000
Quarters > 2 > income Statement > gross Profit
2487000
Quarters > 2 > income Statement > operating Expenses
17407000
Quarters > 2 > income Statement > operating Income
-14920000
Quarters > 2 > income Statement > interest Expense
2257000
Quarters > 2 > income Statement > pretax Income
-16764000
Quarters > 2 > income Statement > net Income
4639000
Quarters > 2 > income Statement > eps
0.04595162153059809
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
100954000
Quarters > 2 > income Statement > income Tax Expense
2000
Quarters > 2 > income Statement > EBITDA
-14180000
Quarters > 2 > income Statement > operating Margin
-544.7243519532676
Quarters > 2 > income Statement > total Other Income Expense Net
-1844000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
33609000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
147000
Quarters > 2 > balance Sheet > inventories
3155000
Quarters > 2 > balance Sheet > total Current Assets
148529000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
165213000
Quarters > 2 > balance Sheet > payables
7282000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
340142000
Quarters > 2 > balance Sheet > equity
-216896000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
4639000
Quarters > 2 > cash Flow > depreciation
327000
Quarters > 2 > cash Flow > change In Working Capital
-5652000
Quarters > 2 > cash Flow > cash From Operations
2719000
Quarters > 2 > cash Flow > capital Expenditures
16000
Quarters > 2 > cash Flow > cash From Investing
-16000
Quarters > 2 > cash Flow > cash From Financing
-88000
Quarters > 2 > cash Flow > net Change In Cash
4022000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.04595162153059809
Quarters > 2 > ratios > PB
-4.3904861832398945
Quarters > 2 > ratios > ROE
-2.138813071702567
Quarters > 2 > ratios > ROA
2.8078904202453803
Quarters > 2 > ratios > FCF
2703000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.9868565169769989
Quarters > 2 > health Score
51
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-123256000
Quarters > 3 > income Statement > cost Of Revenue
-20666000
Quarters > 3 > income Statement > gross Profit
-102590000
Quarters > 3 > income Statement > operating Expenses
-10934000
Quarters > 3 > income Statement > operating Income
-91656000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-87589000
Quarters > 3 > income Statement > net Income
17982000
Quarters > 3 > income Statement > eps
4.458494495685808
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
4033200
Quarters > 3 > income Statement > income Tax Expense
-52000
Quarters > 3 > income Statement > EBITDA
-91100000
Quarters > 3 > income Statement > operating Margin
74.3623028493542
Quarters > 3 > income Statement > total Other Income Expense Net
4067000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
50482000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
481000
Quarters > 3 > balance Sheet > inventories
3155000
Quarters > 3 > balance Sheet > total Current Assets
196509000
Quarters > 3 > balance Sheet > property Plant Equipment
97000
Quarters > 3 > balance Sheet > total Assets
214525000
Quarters > 3 > balance Sheet > payables
5064000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
398159999
Quarters > 3 > balance Sheet > equity
-225601999
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
17982000
Quarters > 3 > cash Flow > depreciation
352000
Quarters > 3 > cash Flow > change In Working Capital
-47779000
Quarters > 3 > cash Flow > cash From Operations
-30466000
Quarters > 3 > cash Flow > capital Expenditures
141000
Quarters > 3 > cash Flow > cash From Investing
1723000
Quarters > 3 > cash Flow > cash From Financing
5000
Quarters > 3 > cash Flow > net Change In Cash
-28825000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
4.458494495685808
Quarters > 3 > ratios > PB
-0.16863489299135156
Quarters > 3 > ratios > ROE
-7.97067405417804
Quarters > 3 > ratios > ROA
8.382239832187391
Quarters > 3 > ratios > FCF
-30607000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
0.2483205685727267
Quarters > 3 > health Score
55
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
29621000
Annuals > 0 > income Statement > cost Of Revenue
15561000
Annuals > 0 > income Statement > gross Profit
14060000
Annuals > 0 > income Statement > operating Expenses
164476000
Annuals > 0 > income Statement > operating Income
-150416000
Annuals > 0 > income Statement > interest Expense
8247000
Annuals > 0 > income Statement > pretax Income
-153367000
Annuals > 0 > income Statement > net Income
-47579000
Annuals > 0 > income Statement > eps
-0.47558074447243215
Annuals > 0 > income Statement > dividends Per Share
2230000
Annuals > 0 > income Statement > shares Outstanding
100044000
Annuals > 0 > income Statement > income Tax Expense
-269000
Annuals > 0 > income Statement > EBITDA
-142428000
Annuals > 0 > income Statement > operating Margin
-507.8018973025894
Annuals > 0 > income Statement > total Other Income Expense Net
-2951000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
50482000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
481000
Annuals > 0 > balance Sheet > inventories
3155000
Annuals > 0 > balance Sheet > total Current Assets
196509000
Annuals > 0 > balance Sheet > property Plant Equipment
97000
Annuals > 0 > balance Sheet > total Assets
214525000
Annuals > 0 > balance Sheet > payables
5064000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
398159999
Annuals > 0 > balance Sheet > equity
-225601999
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-47579000
Annuals > 0 > cash Flow > depreciation
2692000
Annuals > 0 > cash Flow > change In Working Capital
-117459000
Annuals > 0 > cash Flow > cash From Operations
-137999000
Annuals > 0 > cash Flow > capital Expenditures
266000
Annuals > 0 > cash Flow > cash From Investing
125993000
Annuals > 0 > cash Flow > cash From Financing
-255000
Annuals > 0 > cash Flow > net Change In Cash
-11510000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.47558074447243215
Annuals > 0 > ratios > PB
-4.183008339389759
Annuals > 0 > ratios > ROE
21.089795396715434
Annuals > 0 > ratios > ROA
-22.178767043468127
Annuals > 0 > ratios > FCF
-138265000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-4.6678032476958915
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
46803000
Annuals > 1 > income Statement > cost Of Revenue
3962000
Annuals > 1 > income Statement > gross Profit
42841000
Annuals > 1 > income Statement > operating Expenses
365562000
Annuals > 1 > income Statement > operating Income
-322721000
Annuals > 1 > income Statement > interest Expense
8095000
Annuals > 1 > income Statement > pretax Income
-323222000
Annuals > 1 > income Statement > net Income
-284232000
Annuals > 1 > income Statement > eps
-2.9211021242921595
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
97303000
Annuals > 1 > income Statement > income Tax Expense
-252000
Annuals > 1 > income Statement > EBITDA
-305197000
Annuals > 1 > income Statement > operating Margin
-689.5305856462193
Annuals > 1 > income Statement > total Other Income Expense Net
-501000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
113688000
Annuals > 1 > balance Sheet > short Term Investments
121898000
Annuals > 1 > balance Sheet > receivables
41053000
Annuals > 1 > balance Sheet > inventories
41565000
Annuals > 1 > balance Sheet > total Current Assets
331559000
Annuals > 1 > balance Sheet > property Plant Equipment
81372000
Annuals > 1 > balance Sheet > total Assets
423529000
Annuals > 1 > balance Sheet > payables
17960000
Annuals > 1 > balance Sheet > short Term Debt
14117000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
585728000
Annuals > 1 > balance Sheet > equity
-204166000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-284232000
Annuals > 1 > cash Flow > depreciation
9930000
Annuals > 1 > cash Flow > change In Working Capital
-119687000
Annuals > 1 > cash Flow > cash From Operations
-315021000
Annuals > 1 > cash Flow > capital Expenditures
2519000
Annuals > 1 > cash Flow > cash From Investing
153657000
Annuals > 1 > cash Flow > cash From Financing
122749000
Annuals > 1 > cash Flow > net Change In Cash
-42012000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.9211021242921595
Annuals > 1 > ratios > PB
-4.495556255204098
Annuals > 1 > ratios > ROE
139.21612805266304
Annuals > 1 > ratios > ROA
-67.11039857955417
Annuals > 1 > ratios > FCF
-317540000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-6.784607824284768
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
140734000
Annuals > 2 > income Statement > cost Of Revenue
20280000
Annuals > 2 > income Statement > gross Profit
120454000
Annuals > 2 > income Statement > operating Expenses
421479000
Annuals > 2 > income Statement > operating Income
-301025000
Annuals > 2 > income Statement > interest Expense
1440000
Annuals > 2 > income Statement > pretax Income
-293296000
Annuals > 2 > income Statement > net Income
-293654000
Annuals > 2 > income Statement > eps
-3.1379325083883653
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
93582000
Annuals > 2 > income Statement > income Tax Expense
358000
Annuals > 2 > income Statement > EBITDA
-282825000
Annuals > 2 > income Statement > operating Margin
-213.8964287236915
Annuals > 2 > income Statement > total Other Income Expense Net
7729000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
155700000
Annuals > 2 > balance Sheet > short Term Investments
266308000
Annuals > 2 > balance Sheet > receivables
16299000
Annuals > 2 > balance Sheet > inventories
40436000
Annuals > 2 > balance Sheet > total Current Assets
492826000
Annuals > 2 > balance Sheet > property Plant Equipment
100498000
Annuals > 2 > balance Sheet > total Assets
610087000
Annuals > 2 > balance Sheet > payables
30758000
Annuals > 2 > balance Sheet > short Term Debt
10292000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
611567000
Annuals > 2 > balance Sheet > equity
-21447000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-293654000
Annuals > 2 > cash Flow > depreciation
10604000
Annuals > 2 > cash Flow > change In Working Capital
70430000
Annuals > 2 > cash Flow > cash From Operations
-145933000
Annuals > 2 > cash Flow > capital Expenditures
38741000
Annuals > 2 > cash Flow > cash From Investing
89116000
Annuals > 2 > cash Flow > cash From Financing
46776000
Annuals > 2 > cash Flow > net Change In Cash
-15523000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-3.1379325083883653
Annuals > 2 > ratios > PB
-41.159149979018046
Annuals > 2 > ratios > ROE
1369.2078146127662
Annuals > 2 > ratios > ROA
-48.13313511023837
Annuals > 2 > ratios > FCF
-184674000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.3122202168630182
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
235309000
Annuals > 3 > income Statement > cost Of Revenue
449192000
Annuals > 3 > income Statement > gross Profit
-213883000
Annuals > 3 > income Statement > operating Expenses
74647000
Annuals > 3 > income Statement > operating Income
-288530000
Annuals > 3 > income Statement > interest Expense
1075000
Annuals > 3 > income Statement > pretax Income
-289676000
Annuals > 3 > income Statement > net Income
-290023000
Annuals > 3 > income Statement > eps
-3.1405104549047635
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
92349000
Annuals > 3 > income Statement > income Tax Expense
347000
Annuals > 3 > income Statement > EBITDA
-333721000
Annuals > 3 > income Statement > operating Margin
-122.61749444347645
Annuals > 3 > income Statement > total Other Income Expense Net
-1146000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
171223000
Annuals > 3 > balance Sheet > short Term Investments
233967000
Annuals > 3 > balance Sheet > receivables
25401000
Annuals > 3 > balance Sheet > inventories
31015000
Annuals > 3 > balance Sheet > total Current Assets
474059000
Annuals > 3 > balance Sheet > property Plant Equipment
119389000
Annuals > 3 > balance Sheet > total Assets
773821000
Annuals > 3 > balance Sheet > payables
26097000
Annuals > 3 > balance Sheet > short Term Debt
10944000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
544708000
Annuals > 3 > balance Sheet > equity
209146000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-290023000
Annuals > 3 > cash Flow > depreciation
14809000
Annuals > 3 > cash Flow > change In Working Capital
60083000
Annuals > 3 > cash Flow > cash From Operations
-82232000
Annuals > 3 > cash Flow > capital Expenditures
30186000
Annuals > 3 > cash Flow > cash From Investing
-426972000
Annuals > 3 > cash Flow > cash From Financing
-563000
Annuals > 3 > cash Flow > net Change In Cash
-507170000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-3.1405104549047635
Annuals > 3 > ratios > PB
4.1650791657502415
Annuals > 3 > ratios > ROE
-138.67011561301675
Annuals > 3 > ratios > ROA
-37.47933953717978
Annuals > 3 > ratios > FCF
-112418000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.47774628254762885
Annuals > 3 > health Score
16
Valuation > metrics > PE
49.61325420375866
Valuation > metrics > PB
-2.2402069062720225
Valuation > final Score
20.46409495548961
Valuation > verdict
98.5% Overvalued
Profitability > metrics > ROE
-1178.2710829222458
Profitability > metrics > ROA
150.37587222592805
Profitability > metrics > Net Margin
186.46468401486987
Profitability > final Score
60
Profitability > verdict
Adequate
Risk > metrics > Interest Coverage
-2.5976956313010082
Risk > final Score
20
Risk > verdict
High
Liquidity > metrics > Current Ratio
26.197329668172
Liquidity > metrics > Quick Ratio
25.43864127233458
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
7
Prev Profitabilities > 1
39
Prev Profitabilities > 2
27
Prev Risks > 0
6
Prev Risks > 1
4
Prev Risks > 2
-74
Prev Liquidities > 0
98
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:13:35.860Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-16
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-3.88
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. Its pipeline products include FG-3165 and FG-3175, an anti-GAL-9 antibody for treatment of solid tumors. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of FibroGen, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-3.88
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.